Tissue Repair & Regeneration
Hexapeptide-9

Head-to-head trials against an ingredient that already works are rare among cosmetic peptides, and hexapeptide-9 has one. A randomised, double-blinded trial ran a 0.002 per cent cyclised hexapeptide-9 serum against a 0.002 per cent retinol serum and against vehicle for 56 days, measuring crow's feet and forehead wrinkle number, area and roughness, and the peptide came out ahead of retinol on every measure but one. The peptide itself is a six-amino-acid fragment copied from collagen, applied on the principle that a skin cell reading a collagen fragment will build more collagen. Two things qualify the result: the material tested was a cyclised variant, and the number enrolled was never reported.
Last updated
Mechanism
A collagen-fragment mimetic that stimulates fibroblast collagen production; cyclisation improves its stability and skin permeability.
Reported effects
What sources associate with this compound. Reported categories, not outcomes we have graded — each would need its own citation and rung.
- Wrinkle reduction research
- Collagen synthesis research
- Skin ageing context
Manufacturer’s claim vendor marketing
For a proprietary cosmetic ingredient the manufacturer is the originator — there is no upstream to defer to, and this is often the only description that exists. It is reproduced as an attributed claim, with the label its source gave it. It is not graded and it is not evidence — the graded studies are under Literature.
Vendor claim (SpecialChem/Ashland datasheet): "Acts as an anti-wrinkle and skin repairing agent. It helps in reducing the length and depth of wrinkles. It enhances epidermal regeneration, protein synthesis and boosts dermal-epidermal junction key proteins." No n= or duration on fetched page.
- Manufacturer
- Ashland
- Sold as
- Collaxyl IS
Source page — nofollow, because a vendor link is a reference here, not an endorsement.
Dosing on file unverified
0.002% CHP-9 serum, 1-2x/day (56 days)
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Literature on file 5
-
human RCT
Novel Cyclized Hexapeptide-9 Outperforms Retinol Against Skin Aging: A Randomized, Double-Blinded, Active- and Vehicle-Controlled Clinical Trial. graded on: names a randomised controlled trial — the indexed publication type — “Randomized Controlled”
-
human RCT
Efficacy and Tolerability of a Topical Peptide-Hyaluronic Acid Lip Treatment Using a Novel Delivery System in Subjects With and Without Prior Lip Augmentation. graded on: names a randomised controlled trial — the indexed publication type — “Randomized Controlled”
-
computational
A framework for the safety evaluation of peptides in cosmetics. graded on: in-silico safety framework applied through six bioinformatic tools — read from the abstract — “abstract review”
-
human observational
Efficacy of a Postbiotic Formulation Combined With Microneedling for Mild-to-Moderate Acne: A Self-Control Study. graded on: single-arm self-control study, 20 patients, 4-week follow-up — read from the abstract — “abstract review”
-
human case series
In Vivo and Ex Vivo Evaluation of a Novel Method for Topical Delivery of Macromolecules Through the Stratum Corneum for Cosmetic Applications. graded on: two open in-vivo studies in human skin, read out by punch biopsy; the paper reports its own findings as case studies, with no control arm — read from the abstract — “abstract review”
Identity
Skeletal formulathe canonical depiction
Drawn by PubChem from CID 16129319, the identifier on this record.
- Molecular weight
- 582.6
- Molecular formula
- C24H38N8O9
- CAS number
- 885024-94-2
- PubChem CID
- 16129319
- InChI key
- OGNHOGPWQTWKGQ-VGWMRTNUSA-N
- SMILES
- C1C[C@H](N(C1)C(=O)CN)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O
- InChI
- InChI=1S/C24H38N8O9/c25-11-19(35)31-9-1-3-15(31)22(38)29-13(5-7-17(26)33)21(37)28-12-20(36)32-10-2-4-16(32)23(39)30-14(24(40)41)6-8-18(27)34/h13-16H,1-12,25H2,(H2,26,33)(H2,27,34)(H,28,37)(H,29,38)(H,30,39)(H,40,41)/t13-,14-,15-,16-/m0/s1
Also called
- Collaxyl IS
- Hexapeptide-9
Notes unverified prose
2025 RCT: cyclized Hexapeptide-9 (CHP-9) outperformed retinol for skin aging at 56 days; 28-day study: improved elasticity & firmness; RCT: cyclized hexapeptide-9 (CHP-9) outperformed retinol
Not on file 2
1 of the 8 fields we track hold nothing on this record, and each says why. 1 further absence is named below. A blank field is a bug; a named absence is a finding.
- amino-acid sequencenothing we hold supplies it
- half-lifenothing we hold supplies it
Each field links to every other record missing the same thing. The full ledger holds 765 gaps across 163 records.